These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 17984668

  • 1. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
    Zanchetti A, Hennig M, Baurecht H, Tang R, Cuspidi C, Carugo S, Mancia G.
    J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668
    [Abstract] [Full Text] [Related]

  • 2. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A, Hennig M, Hollweck R, Bond G, Tang R, Cuspidi C, Parati G, Facchetti R, Mancia G.
    Circulation; 2009 Sep 22; 120(12):1084-90. PubMed ID: 19738145
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atheroscelerosis (ELSA).
    Zanchetti A.
    Blood Press Suppl; 1996 Sep 22; 4():30-5. PubMed ID: 8973780
    [Abstract] [Full Text] [Related]

  • 4. [The preliminary clinical evidence from the ELSA study. The European Lacidipine Study on Atherosclerosis].
    Leonetti G.
    Ann Ital Med Int; 1995 Oct 22; 10 Suppl():74S-77S. PubMed ID: 8562272
    [Abstract] [Full Text] [Related]

  • 5. Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
    Agabiti-Rosei E, Trimarco B, Muiesan ML, Reid J, Salvetti A, Tang R, Hennig M, Baurecht H, Parati G, Mancia G, Zanchetti A, ELSA Echocardiographic Substudy Group.
    J Hypertens; 2005 May 22; 23(5):1091-8. PubMed ID: 15834297
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
    Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R.
    J Hypertens; 1998 Jul 22; 16(7):949-61. PubMed ID: 9794735
    [Abstract] [Full Text] [Related]

  • 8. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
    Mancia G, Parati G, Bilo G, Maronati A, Omboni S, Baurecht H, Hennig M, Zanchetti A.
    J Hypertens; 2007 May 22; 25(5):1087-94. PubMed ID: 17414674
    [Abstract] [Full Text] [Related]

  • 9. Association of waist and hip circumference with 12-year progression of carotid intima-media thickness in elderly women.
    Hassinen M, Lakka TA, Komulainen P, Haapala I, Nissinen A, Rauramaa R.
    Int J Obes (Lond); 2007 Sep 22; 31(9):1406-11. PubMed ID: 17372615
    [Abstract] [Full Text] [Related]

  • 10. Does the new International Diabetes Federation definition of metabolic syndrome improve prediction of coronary artery disease and carotid intima-media thickening?
    Timóteo A, Santos R, Lima S, Mamede A, Fernandes R, Ferreira R.
    Rev Port Cardiol; 2009 Feb 22; 28(2):173-81. PubMed ID: 19438152
    [Abstract] [Full Text] [Related]

  • 11. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
    Mancia G, Facchetti R, Parati G, Zanchetti A.
    Circulation; 2012 Jul 31; 126(5):569-78. PubMed ID: 22761453
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment.
    Mancia G, Facchetti R, Parati G, Zanchetti A.
    J Hypertens; 2012 Jun 31; 30(6):1241-51. PubMed ID: 22499291
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lacidipine: a review of its use in the management of hypertension.
    McCormack PL, Wagstaff AJ.
    Drugs; 2003 Jun 31; 63(21):2327-56. PubMed ID: 14524737
    [Abstract] [Full Text] [Related]

  • 17. Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity study.
    Paliotti R, Ciulla MM, Hennig M, Tang R, Bond MG, Mancia G, Magrini F, Zanchetti A.
    J Hypertens; 2005 Jun 31; 23(6):1203-9. PubMed ID: 15894896
    [Abstract] [Full Text] [Related]

  • 18. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis.
    Bond MG, Mercuri M.
    J Cardiovasc Pharmacol; 1995 Jun 31; 25 Suppl 3():S11-6. PubMed ID: 8852539
    [Abstract] [Full Text] [Related]

  • 19. Defining the metabolic syndrome construct: Multi-Ethnic Study of Atherosclerosis (MESA) cross-sectional analysis.
    Vaidya D, Szklo M, Liu K, Schreiner PJ, Bertoni AG, Ouyang P.
    Diabetes Care; 2007 Aug 31; 30(8):2086-90. PubMed ID: 17485573
    [Abstract] [Full Text] [Related]

  • 20. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA).
    Tang R, Hennig M, Thomasson B, Scherz R, Ravinetto R, Catalini R, Rubba P, Zanchetti A, Bond MG.
    J Hypertens; 2000 Feb 31; 18(2):197-201. PubMed ID: 10694188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.